Who invested in Paragen Bio?
Paragen Bio's investors include AbbVie.
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$4.3Mraised across 1 round since 2018, from 1 source
Paragen Bio's investors include AbbVie.
Paragen Bio has raised $4.3M across 1 round since 2018.
Paragen Bio's most recent round was a Venture of $4.3M in Aug 2018.
Its most recent round, $4.3M in Aug 2018, is also its largest on record.
Paragen Bio's first round on record, in Aug 2018, was backed by AbbVie.
Paragen Bio's latest named round is a Venture, in Aug 2018.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.